Harvey Capital Management Inc I Bio, Inc. Transaction History

Harvey Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$1.18 - $2.62 $88,500 - $196,500	-75,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.05 - $2.24 $36,750 - $78,400	35,000 Added 87.5%	75,000 $78,000
Q3 2020 Oct 27, 2020	BUY	$1.7 - $6.41 $8,500 - $32,050	5,000 Added 14.29%	40,000 $81,000
Q2 2020 Aug 05, 2020	BUY	$0.87 - $2.46 $30,450 - $86,100	35,000 New	35,000 $77,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $20.5M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Harvey Capital Management Inc with notifications on news.